down arrow

Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
105.70
2.83 (2.75%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 30.6 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Bal Pharma Ltd stock-summary
stock-summary
Bal Pharma Ltd
Micro Cap
Pharmaceuticals & Drugs
Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations.
Company Coordinates stock-summary
Company Details
21 & 22 Bommasandra Indl Area, Hosur Road Bangalore Karnataka : 560092
stock-summary
Tel:
stock-summary
secretarial@balpharma.com/info@balp
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 15.92 Cr
Number of Shares
1.59 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
09-Sep-2024
1.59
15.92
116500
10
Issued under ESOP Scheme
08-Nov-2023
1.58
15.80
114500
10
Issued under ESOP Scheme
14-Nov-2022
1.57
15.69
117500
10
Issued under ESOP Scheme
13-Apr-2022
1.56
15.57
750000
10
Conversion of Warrants
17-Mar-2021
1.48
14.82
650000
10
Conversion of Warrants
13-Apr-2016
1.42
14.17
1300000
10
Conversion of Warrants
16-Apr-2014
1.29
12.87
1760984
10
Conversion of Warrants
16-Apr-2014
1.29
12.87
1760984
10
Conversion of Warrants
12-Feb-2014
1.11
11.11
537764
10
Allotment of Equity To Others
12-Feb-2014
1.11
11.11
537764
10
Allotment of Equity To Others
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (0.14%)

Promoter with highest holding

Shailesh Siroya (17.24%)

Highest Public shareholder

Prakash Chandra Jain (3.65%)

Individual Investors Holdings

32.49%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Shailesh Siroya
Managing Director
1.22 cr
C V Srinivas
Independent Director
38.0 k
Himesh Virupakshaya
Executive Director
33.22 lacs
H S Venkatesh
Independent Director
32.0 k
Nicola Neeladri
Independent Director
49.0 k
Jatish Sheth
Independent Director
46.0 k
Kotian Chittananda Damodar
Whole-time Director
18.74 lacs
Abdul Basith
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
73 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 168 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.17%

stock-summary
Debt Equity

1.89

stock-summary
Return on Equity

11.14%

stock-summary
Price to Book

2.38